Enzo Biochem, Inc.

Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates throu…

Medical - Diagnostics & Research

US, New York [HQ]

Analysts
Dividend Payments
Government Awards
Insiders
Lobbying Expenses
Segment Revenues
Shareholder Structure
Supply / Portfolio
Valuation Models [Soon]

Major Shareholders · Proxy Ben. Owners

Shareholders

Major Shareholders · Structure

Breakdown

The breakdown presents the total weighting of the relevant parties: Institutes, Insiders & Public. for Enzo Biochem, Inc.

Enzo Biochem, Inc. can't present any analysts estimates at the moment detail analysis.

Intraday

Shares Outstanding

52,244,100

Volume

306,880

Volume on Avg.

152,791

Beneficial Owners Beta

Beneficial owners who control a significant portion of the shares outstanding.

SEC Source

Form 3/4/5

Owner	Shares	Equivalence - $0.70 per share	Last Form/Filing	Last Transaction
10% Holder
- No data -
Officers/Directors Below 10%
Radoff Bradley Louis Internal : Director	4,311,517	$3,018,061.90	02/13/23	A 75,188 x $0 = $0
Couchman Jonathan Internal : Director	0	$0	12/02/24	0 x $0 = $0
Eckert Patricia Internal : Chief Financial Officer	0	$0	11/15/22	0 x $0 = $0
Cannon Kara Internal : Chief Executive Officer	15,100	$10,570.00	01/31/23	A 12,600 x $0 = $0
Pully Steven J Internal : Director	97,095	$67,966.50	02/02/24	A 79,365 x $0 = $0
Tagliaferri Mary Internal : Director	0	$0	01/13/21	0 x $0 = $0
Walters Ian B. Internal : Director	39,063	$27,344.10	04/29/22	A 39,063 x $0 = $0
Erfanian Hamid Internal : Chief Executive Officer	374,600	$262,220.00	11/28/22	P 100,000 x $1.97 = $197,000.00
Bench David Internal : Chief Financial Officer	2,500	$1,750.00	04/14/22	A 1,620 x $2.90 = $4,698.00